3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
23
Recurrence
5
Neoplasms
3
Plasmablastic Lymphoma
2
Leukemia, Myeloid, Acute
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Plasmacytoma
1
Myelodysplastic Syndromes
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia, Plasma Cell
1
Immunoglobulin Light-chain Amyloidosis
1
Interventions
Dexamethasone
2
Bortezomib
2
pomalidomide
1
isatuximab
1
fludarabine phosphate
1
elotuzumab
1
carfilzomib
1
belantamab mafodotin
1
Whole-Body Irradiation
1
Tacrolimus
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Lenalidomide
1
Fecal Microbiota Transplantation
1
Etoposide
1
Cyclosporine
1
Cyclophosphamide
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms, Plasma Cell
×
daratumumab
×
30 days
×
Clear all
No trials found.